Table 2.
Hazard ratios of triglyceride glucose (TyG) index for hypertension in participants with different waist circumstance.
| Variable | N | HR (95% CI) P value | ||
|---|---|---|---|---|
| Crude model | Model I | Model II | ||
| Normal waist | ||||
| TyG | 2429 | 1.10 (0.95, 1.28) 0.20 | 1.11 (0.90, 1.37) 0.34 | 1.05 (0.84, 1.30) 0.68 |
| TyG quartiles | ||||
| Q1 (4.96–8.18) | 832 | 1 | 1 | 1 |
| Q2 (8.18–8.52) | 674 | 1.09 (0.88, 1.36) 0.41 | 1.16 (0.91, 1.49) 0.24 | 1.13 (0.88, 1.45) 0.33 |
| Q3 (8.52–8.95) | 555 | 1.13 (0.90, 1.41) 0.29 | 1.02 (0.77, 1.36) 0.89 | 0.93 (0.69, 1.24) 0.61 |
| Q4 (8.95–12.14) | 368 | 1.05 (0.81, 1.36) 0.70 | 1.15 (0.81, 1.63) 0.44 | 1.07 (0.75, 1.52) 0.72 |
| P for trend | 0.49 | 0.61 | 0.93 | |
| Central obesity prophase | ||||
| TyG | 886 | 1.11 (0.91, 1.35) 0.29 | 1.64 (1.18, 2.27) < 0.01 | 1.57 (1.13, 2.16) < 0.01 |
| TyG quartiles | ||||
| Q1 (4.96–8.18) | 180 | 1 | 1 | 1 |
| Q2 (8.18–8.52) | 230 | 1.33 (0.90, 1.96) 0.15 | 1.55 (0.95, 2.52) 0.08 | 1.37 (0.84, 2.23) 0.21 |
| Q3 (8.52–8.95) | 241 | 1.17 (0.79, 1.73) 0.44 | 1.80 (1.08, 2.98) 0.02 | 1.63 (0.98, 2.71) 0.06 |
| Q4 (8.95–12.14) | 235 | 1.48 (1.01, 2.16) 0.04 | 2.34 (1.35, 4.06) < 0.01 | 2.03 (1.17, 3.54) 0.01 |
| P for trend | < 0.01 | < 0.01 | < 0.01 | |
| Central obesity | ||||
| TyG | 1592 | 1.07 (0.94, 1.21) 0.31 | 0.92 (0.75, 1.12) 0.41 | 0.84 (0.69, 1.03) 0.10 |
| TyG quartiles | ||||
| Q1 (4.96–8.18) | 240 | 1 | 1 | 1 |
| Q2 (8.18–8.52) | 331 | 1.10 (0.82, 1.48) 0.51 | 0.84 (0.59, 1.18) 0.30 | 0.76 (0.54, 1.07) 0.12 |
| Q3 (8.52–8.95) | 429 | 1.01 (0.76, 1.34) 0.96 | 0.72 (0.51, 1.01) 0.05 | 0.66 (0.47, 0.92) 0.01 |
| Q4 (8.95–12.14) | 592 | 1.12 (0.86, 1.46) 0.40 | 0.72 (0.51, 1.03) 0.07 | 0.64 (0.45, 0.91) 0.01 |
| P for trend | 0.52 | 0.07 | 0.02 | |
Adjust I model adjust for: age, gender, smoke, drink, marital status, education level, sleep duration, BMI, diabetes, WBC, PLT, MCV, hemoglobin, hematocrit, CRP, BUN, creatine, uric acid, HDL-C, LDL-C, pulse, use of hypoglycemic drugs, use of lipid-lowering drugs and per capita household consumption; Adjust II model adjust for: age, gender, smoke, drink, marital status, education level, sleep duration, BMI, diabetes, WBC, PLT, MCV, hemoglobin, hematocrit, CRP, BUN, creatine, uric acid, HDL-C, LDL-C, pulse, use of hypoglycemic drugs, use of lipid-lowering drugs, per capita household consumption, SBP and DBP.
BMI body mass index, BUN blood urea nitrogen, CRP C-reactive protein, CI confidence interval, DBP diastolic blood pressure, FBG fasting blood glucose, HbA1c hemoglobin A1c, HDL-C high-density lipoprotein cholesterol, HR hazard ratio, LDL-C low-density lipoprotein cholesterol, MCV mean corpuscular volume, PLT platelet, SBP systolic blood pressure, TyG triglyceride glucose index, WBC white blood cell.